AVO — Advanced Oncotherapy Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -13.7 | -21.1 | -20.8 | -25.3 | -29.5 |
Depreciation | |||||
Non-Cash Items | -0.136 | 6.1 | 2.08 | 6.84 | 9.5 |
Discontinued Operations | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 3.85 | 12.9 | -6.86 | -4.12 | -11.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -9.59 | -1.66 | -23.6 | -20.2 | -29.6 |
Capital Expenditures | -8.56 | -12.1 | -12 | -7.44 | -9.29 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0.013 | 0.326 | 0.003 | 0 |
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -8.56 | -12.1 | -11.7 | -7.43 | -9.29 |
Financing Cash Flow Items | 0.009 | -0.626 | -0.665 | -1.06 | 1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 16.8 | 14.7 | 37.5 | 26.7 | 40.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.39 | 0.957 | 2.22 | -0.918 | 1.94 |